S Krajewski1, B Neumann2, J Kurz2, N Perle2, M Avci-Adali2, G Cattaneo3, H P Wendel2. 1. From the Department of Thoracic, Cardiac and Vascular Surgery (S.K., B.N., J.K., N.P., M.A.-A., H.P.W.), Clinical Research Laboratory, University Hospital Tuebingen, Tuebingen, Germany stefanie.krajewski@uni-tuebingen.de. 2. From the Department of Thoracic, Cardiac and Vascular Surgery (S.K., B.N., J.K., N.P., M.A.-A., H.P.W.), Clinical Research Laboratory, University Hospital Tuebingen, Tuebingen, Germany. 3. Acandis GmbH & Co KG (G.C.), Pforzheim, Germany.
Abstract
BACKGROUND AND PURPOSE: Stent-assisted coiling is routinely used for the endovascular treatment of complex or wide-neck intracranial aneurysms. However, in-stent thrombosis, thromboembolic events, and ischemic complications remain a major concern associated with stent implants. Therefore, a novel low-profile neurovascular stent with a bare metal surface was investigated with regard to thrombogenicity and endothelialization and compared with the same stent coated with albumin or heparin. MATERIALS AND METHODS: The bare metal and heparin- or albumin-coated stents were loaded in heparin-coated tubing, which was then filled with heparinized human blood (n = 5) and circulated at 150 mL/min and 37°C for 60 minutes. Before and after circulation, measurement of various inflammation and coagulation markers and scanning electron microscopy were performed. Endothelialization of the stents was investigated in an in vitro model including human umbilical vascular endothelial cells. RESULTS: Our results showed that platelet loss and platelet activation and activation of the coagulation cascade, which are induced by the bare metal stents, were significantly reduced by heparin or albumin coating. Adverse effects on erythrocytes, leukocytes, and the complement cascade were not induced by the bare metal or coated stents. Moreover, the bare metal and albumin-coated stents showed good endothelialization properties. CONCLUSIONS: Albumin and heparin coatings clearly improve the thrombogenicity of the stents and thus may represent fundamental progress in the treatment of intracranial aneurysms. Moreover, preclinical evaluation of neurovascular stents under physiologic conditions supports and accelerates the development of more biocompatible neurovascular stents.
BACKGROUND AND PURPOSE: Stent-assisted coiling is routinely used for the endovascular treatment of complex or wide-neck intracranial aneurysms. However, in-stent thrombosis, thromboembolic events, and ischemic complications remain a major concern associated with stent implants. Therefore, a novel low-profile neurovascular stent with a bare metal surface was investigated with regard to thrombogenicity and endothelialization and compared with the same stent coated with albumin or heparin. MATERIALS AND METHODS: The bare metal and heparin- or albumin-coated stents were loaded in heparin-coated tubing, which was then filled with heparinized human blood (n = 5) and circulated at 150 mL/min and 37°C for 60 minutes. Before and after circulation, measurement of various inflammation and coagulation markers and scanning electron microscopy were performed. Endothelialization of the stents was investigated in an in vitro model including human umbilical vascular endothelial cells. RESULTS: Our results showed that platelet loss and platelet activation and activation of the coagulation cascade, which are induced by the bare metal stents, were significantly reduced by heparin or albumin coating. Adverse effects on erythrocytes, leukocytes, and the complement cascade were not induced by the bare metal or coated stents. Moreover, the bare metal and albumin-coated stents showed good endothelialization properties. CONCLUSIONS: Albumin and heparin coatings clearly improve the thrombogenicity of the stents and thus may represent fundamental progress in the treatment of intracranial aneurysms. Moreover, preclinical evaluation of neurovascular stents under physiologic conditions supports and accelerates the development of more biocompatible neurovascular stents.
Authors: R Moer; Y Myreng; P Mølstad; P Albertsson; P Gunnes; B Lindvall; R Wiseth; K Ytre-Arne; J Kjekshus; S Golf Journal: J Am Coll Cardiol Date: 2001-11-15 Impact factor: 24.094
Authors: J Mocco; Kyle M Fargen; Felipe C Albuquerque; Bernard R Bendok; Alan S Boulos; Jeffrey S Carpenter; David J Fiorella; Brian L Hoh; Jay U Howington; Kenneth M Liebman; Sabareesh K Natarajan; Ansaar T Rai; Rafael Rodriguez-Mercado; Adnan H Siddiqui; Kenneth V Snyder; Erol Veznedaroglu; L Nelson Hopkins; Elad I Levy Journal: Neurosurgery Date: 2011-10 Impact factor: 4.654
Authors: Joshua B Slee; Ivan S Alferiev; Chandrasekaran Nagaswami; John W Weisel; Robert J Levy; Ilia Fishbein; Stanley J Stachelek Journal: Biomaterials Date: 2016-02-08 Impact factor: 12.479
Authors: Stefanie Krajewski; Tanja Nathan; Bernd Neumann; Sebastian Hoffmann; Martin Abel; Annette Koggel; Christian Schlensak; Hans P Wendel Journal: J Mater Sci Mater Med Date: 2015-02-11 Impact factor: 3.896
Authors: Silviya Boyadzhieva; Katharina Sorg; Martin Danner; Sarah C L Fischer; René Hensel; Bernhard Schick; Gentiana Wenzel; Eduard Arzt; Klaus Kruttwig Journal: Polymers (Basel) Date: 2019-05-31 Impact factor: 4.967
Authors: Hans Henkes; Pervinder Bhogal; Marta Aguilar Pérez; Tim Lenz-Habijan; Catrin Bannewitz; Marcus Peters; Christina Sengstock; Oliver Ganslandt; Pedro Lylyk; Hermann Monstadt Journal: Interv Neuroradiol Date: 2019-06-27 Impact factor: 1.610
Authors: Giorgio Cattaneo; Christoph Brochhausen; Ruben Mühl-Benninghaus; Frederik Fries; Mara Kießling; Toshiki Tomori; Stefanie Krajewski; Andreas Simgen; Sabina Bauer; Natascha Hey; Eduard Brynda; Johanka Taborska; Tomáš Riedel; Wolfgang Reith Journal: Cardiovasc Intervent Radiol Date: 2021-12-16 Impact factor: 2.740